NARI Inari Medical Inc

Price (delayed)

$91.37

Market cap

$4.54B

P/E Ratio

315.07

Dividend/share

N/A

EPS

$0.29

Enterprise value

$4.44B

Highlights
NARI's gross profit has soared by 144% YoY and by 23% QoQ
The revenue has surged by 139% year-on-year and by 22% since the previous quarter
The quick ratio has soared by 83% YoY but it has contracted by 28% from the previous quarter
The stock's price to earnings (P/E) is 67% more than its last 4 quarters average of 188.2
The EPS has dropped by 52% year-on-year and by 33% since the previous quarter

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
49.68M
Market cap
$4.54B
Enterprise value
$4.44B
Valuations
Price to earnings (P/E)
315.07
Price to book (P/B)
21.17
Price to sales (P/S)
26.51
EV/EBIT
243.7
EV/EBITDA
220.7
EV/Sales
26.08
Earnings
Revenue
$170.12M
EBIT
$18.21M
EBITDA
$20.1M
Free cash flow
$5.24M
Per share
EPS
$0.29
Free cash flow per share
$0.11
Book value per share
$4.32
Revenue per share
$3.45
TBVPS
$4.75
Balance sheet
Total assets
$234.58M
Total liabilities
$20.97M
Debt
$789,000
Equity
$213.61M
Working capital
$200.66M
Liquidity
Debt to equity
0
Current ratio
10.73
Quick ratio
9.97
Net debt/EBITDA
-5.08
Margins
EBITDA margin
11.8%
Gross margin
91.2%
Net margin
10.1%
Operating margin
12.5%
Efficiency
Return on assets
7.8%
Return on equity
8.7%
Return on invested capital
27.1%
Return on capital employed
8.5%
Return on sales
10.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
0.33%
1 week
8.55%
1 month
-0.89%
1 year
93.46%
YTD
4.67%
QTD
-14.61%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$170.12M
Gross profit
$155.09M
Operating income
$21.3M
Net income
$17.15M
Gross margin
91.2%
Net margin
10.1%
NARI's gross profit has soared by 144% YoY and by 23% QoQ
The revenue has surged by 139% year-on-year and by 22% since the previous quarter
Inari Medical's net margin has soared by 87% YoY and by 2% from the previous quarter
The company's operating margin rose by 42% YoY but it fell by 5% QoQ

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
315.07
P/B
21.17
P/S
26.51
EV/EBIT
243.7
EV/EBITDA
220.7
EV/Sales
26.08
The stock's price to earnings (P/E) is 67% more than its last 4 quarters average of 188.2
The EPS has dropped by 52% year-on-year and by 33% since the previous quarter
The price to book (P/B) is 12% higher than the last 4 quarters average of 18.9
The equity is up by 7% since the previous quarter
The revenue has surged by 139% year-on-year and by 22% since the previous quarter
The P/S is 12% above the last 4 quarters average of 23.7

Efficiency

How efficient is Inari Medical business performance
NARI's return on invested capital has surged by 163% year-on-year but it is down by 7% since the previous quarter
The return on sales has surged by 55% year-on-year
The company's return on assets rose by 20% YoY
The return on equity has declined by 15% since the previous quarter

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The quick ratio has soared by 83% YoY but it has contracted by 28% from the previous quarter
The current ratio has surged by 77% year-on-year but it has declined by 28% since the previous quarter
Inari Medical's debt is 100% less than its equity
NARI's debt to equity has soared by 100% YoY
Inari Medical's debt has plunged by 97% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.